Michael Matson

Stock Analyst at Needham

(2.66)
# 2,066
Out of 4,711 analysts
21
Total ratings
66.67%
Success rate
12.41%
Average return

Stocks Rated by Michael Matson

Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408$423
Current: $178.16
Upside: +137.43%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $8.48
Upside: +961.32%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $98.22
Upside: -46.04%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $82.63
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $237.27
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $88.95
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $47.59
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $364.60
Upside: -
Mobileye
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $17.51
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $71.65
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $2.50
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $1.25
Upside: -